Songqing He

3.9k total citations
108 papers, 2.4k citations indexed

About

Songqing He is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Songqing He has authored 108 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 33 papers in Epidemiology and 33 papers in Hepatology. Recurrent topics in Songqing He's work include Liver Disease Diagnosis and Treatment (23 papers), Liver Disease and Transplantation (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Songqing He is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Liver Disease and Transplantation (18 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Songqing He collaborates with scholars based in China, United States and United Kingdom. Songqing He's co-authors include Stephen Tomlinson, Bo Tang, Carl Atkinson, Shengguang Yuan, Guandou Yuan, Junfei Jin, Zhenran Wang, Guangying Qi, Shuiping Yu and Biao Lei and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Nature reviews. Immunology.

In The Last Decade

Songqing He

102 papers receiving 2.4k citations

Peers

Songqing He
Lu Zheng China
Hua Ye China
Jian Wu China
Wen Xu China
Oliver Tschopp Switzerland
Hyon‐Seung Yi South Korea
Chuan Liu China
Lu Zheng China
Songqing He
Citations per year, relative to Songqing He Songqing He (= 1×) peers Lu Zheng

Countries citing papers authored by Songqing He

Since Specialization
Citations

This map shows the geographic impact of Songqing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songqing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songqing He more than expected).

Fields of papers citing papers by Songqing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Songqing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songqing He. The network helps show where Songqing He may publish in the future.

Co-authorship network of co-authors of Songqing He

This figure shows the co-authorship network connecting the top 25 collaborators of Songqing He. A scholar is included among the top collaborators of Songqing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Songqing He. Songqing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yühong, Siyang Li, Jianfeng Zheng, et al.. (2025). Self-supervised learning model integrates plain and contrast-enhanced CT for preoperatively identifying gangrenous cholecystitis: a multicenter retrospective cohort study. International Journal of Surgery. 111(11). 7622–7632.
2.
Xie, Shuyun, et al.. (2025). Liver resection in stage 0-A HCC in segments 7/8: a propensity-matched analysis comparing open, laparoscopic, and robotic approach. Surgical Endoscopy. 39(3). 1902–1914. 2 indexed citations
3.
Lin, Chengjie, Biao Lei, Shilian Chen, et al.. (2023). Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling. American Journal of Transplantation. 23(4). 484–497. 5 indexed citations
4.
Peng, Bo, Shilian Chen, Kai Hu, et al.. (2023). Transcriptome sequencing and metabolome analysis reveal the metabolic reprogramming of partial hepatectomy and extended hepatectomy. BMC Genomics. 24(1). 532–532. 4 indexed citations
5.
Wang, Yong, Shuangjiang Li, Jiaping Liu, et al.. (2023). Burden of liver cancer due to hepatitis C from 1990 to 2019 at the global, regional, and national levels. Frontiers in Oncology. 13. 1218901–1218901. 3 indexed citations
6.
Wei, Jie, et al.. (2023). Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019. World Journal of Hepatology. 15(11). 1210–1225. 5 indexed citations
7.
Ouyang, Guoqing, Zhipeng Liu, Yong Wang, et al.. (2023). Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning. Frontiers in Immunology. 14. 1251750–1251750. 17 indexed citations
8.
Peng, Ning, Linfeng Mao, Yiwen Tao, et al.. (2022). Callispheres® drug-eluting beads transarterial chemoembolization might be an efficient and safety down-staging therapy in unresectable liver cancer patients. World Journal of Surgical Oncology. 20(1). 254–254. 2 indexed citations
9.
Guo, Zhenya, Yonglian Zeng, Zefeng Wang, et al.. (2022). Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice. Frontiers in Immunology. 12. 785287–785287. 14 indexed citations
10.
Lai, Shihui, et al.. (2021). Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation. Frontiers in Cell and Developmental Biology. 9. 783088–783088. 18 indexed citations
11.
Shu, Gege, Huizhao Su, Shihui Lai, et al.. (2021). LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3. Journal of Experimental & Clinical Cancer Research. 40(1). 45–45. 33 indexed citations
12.
Zeng, Yonglian, Zhenya Guo, Zhigao Hu, et al.. (2020). FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function. Biomedicine & Pharmacotherapy. 125. 110029–110029. 13 indexed citations
13.
Hu, Zhigao, Shun Zhang, Wei Cao, et al.. (2020). DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling. Life Sciences. 378. 118029–118029. 12 indexed citations
14.
Zhou, Yi, Guandou Yuan, Fudi Zhong, & Songqing He. (2020). Roles of the complement system in alcohol-induced liver disease. Clinical and Molecular Hepatology. 26(4). 677–685. 21 indexed citations
15.
Lin, Chengjie, Zhigao Hu, Guandou Yuan, Biao Lei, & Songqing He. (2018). Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis. World Journal of Hepatology. 10(10). 662–669. 16 indexed citations
16.
Tang, Bo, Guangying Qi, Fang Tang, et al.. (2016). Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell–Like Behaviors in Hepatocellular Carcinoma. Cancer Research. 76(22). 6520–6532. 71 indexed citations
17.
Tang, Bo, Fang Tang, Zhenran Wang, et al.. (2016). Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signaling. Journal of Experimental & Clinical Cancer Research. 35(1). 82–82. 48 indexed citations
18.
Jin, Junfei, et al.. (2016). Aldo-keto Reductase Family 1 Member B 10 Mediates Liver Cancer Cell Proliferation through Sphingosine-1-Phosphate. Scientific Reports. 6(1). 22746–22746. 39 indexed citations
19.
Lei, Biao, et al.. (2015). A Comprehensive Method for Predicting Fatal Liver Failure of Patients With Liver Cancer Resection. Medicine. 94(17). e784–e784. 7 indexed citations
20.
Xiu, Meihong, Colin N. Haile, Songqing He, et al.. (2012). Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study. Psychological Medicine. 43(8). 1651–1660. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026